目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value

4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation

5 Market Outlook
5.1. Market value forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Have there been any recent developments in the market?

8 Company Profiles
8.1. BeiGene Ltd
8.2. Shanghai Kehua Bio-engineering Co Ltd
8.3. Sinovac Biotech Ltd.
8.4. Novo Nordisk A/S

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: China biotechnology industry value: $ billion, 2017-22
Table 2: China biotechnology industry category segmentation: % share, by value, 2017-2022
Table 3: China biotechnology industry category segmentation: $ billion, 2017-2022
Table 4: China biotechnology industry geography segmentation: $ billion, 2022
Table 5: China biotechnology industry value forecast: $ billion, 2022-27
Table 6: BeiGene Ltd: key facts
Table 7: BeiGene Ltd: Annual Financial Ratios
Table 8: BeiGene Ltd: Key Employees
Table 9: BeiGene Ltd: Key Employees Continued
Table 10: BeiGene Ltd: Key Employees Continued
Table 11: Shanghai Kehua Bio-engineering Co Ltd: key facts
Table 12: Shanghai Kehua Bio-engineering Co Ltd: Annual Financial Ratios
Table 13: Shanghai Kehua Bio-engineering Co Ltd: Key Employees
Table 14: Sinovac Biotech Ltd.: key facts
Table 15: Sinovac Biotech Ltd.: Annual Financial Ratios
Table 16: Sinovac Biotech Ltd.: Key Employees
Table 17: Novo Nordisk A/S: key facts
Table 18: Novo Nordisk A/S: Annual Financial Ratios
Table 19: Novo Nordisk A/S: Key Employees
Table 20: Novo Nordisk A/S: Key Employees Continued
Table 21: China size of population (million), 2018-22
Table 22: China gdp (constant 2005 prices, $ billion), 2018-22
Table 23: China gdp (current prices, $ billion), 2018-22
Table 24: China inflation, 2018-22
Table 25: China consumer price index (absolute), 2018-22
Table 26: China exchange rate, 2018-22

List of Figures
Figure 1: China biotechnology industry value: $ billion, 2017-22
Figure 2: China biotechnology industry category segmentation: $ billion, 2017-2022
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2022
Figure 4: China biotechnology industry value forecast: $ billion, 2022-27
Figure 5: Forces driving competition in the biotechnology industry in China, 2022
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2022
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2022
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2022
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2022
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2022